David Wilson

This inventor holds 4 USPTO granted patents. Top assignees: The General Hospital Corporation, Zyomix, Inc., Zyomyx, Incorporated. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Wilson. Retrieved from https://idiyas.com/inventor/david-wilson-fz0vhat0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 50.0

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 25(Granted Patents)

Company Filing History:

2 out of 3,076

The General Hospital Corporation

Years Active: 2004-2007

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7183392 - Site-specific, covalent bioconjugation of proteins (2007-02-27),

2. 7138253 - Streptavidin-binding peptides and uses thereof (2006-11-21),

3. 6841359 - Streptavidin-binding peptides and uses thereof (2005-01-11),

4. 6720165 - Methods for making antibody fragments and compositions resulting therefrom (2004-04-13),

Title: The Innovations of David Wilson

Introduction

David Wilson is a notable inventor based in Hayward, California. He has made significant contributions to the field of bioconjugation and protein interactions. With a total of 4 patents, Wilson's work has advanced the understanding and application of protein chemistry.

Latest Patents

One of Wilson's latest patents focuses on site-specific, covalent bioconjugation of proteins. This invention provides heterofunctional crosslinking groups that include a covalent core component and various linking groups. Another significant patent involves streptavidin-binding peptides, which exhibit high affinity for streptavidin. These peptides can be utilized as part of fusion proteins to enhance the detection, quantitation, and purification of proteins of interest.

Career Highlights

Throughout his career, David Wilson has worked with prominent organizations such as The General Hospital Corporation and Zyomyx, Incorporated. His experience in these institutions has allowed him to develop innovative solutions in protein chemistry.

Collaborations

Wilson has collaborated with esteemed colleagues, including Jack W. Szostak and Anthony Dominic Keefe. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

David Wilson's contributions to the field of bioconjugation and protein interactions highlight his innovative spirit and dedication to scientific advancement. His patents and collaborations reflect a commitment to enhancing the understanding of protein chemistry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]